eupatorin has been researched along with genkwanin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Androutsopoulos, VP; Papakyriakou, A; Spandidos, DA; Vourloumis, D | 1 |
Emami, SA; Taleghani, A; Tayarani-Najaran, Z | 1 |
Chen, LC; Hsu, KC; Huang, HL; Huang, WJ; Lien, ST; Lin, TE; Ngo, ST; Pan, SL; Sung, TY; Tseng, HJ; Wu, YW; Yen, SC | 1 |
1 review(s) available for eupatorin and genkwanin
Article | Year |
---|---|
Artemisia: a promising plant for the treatment of cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisia; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Neoplasms, Experimental; Plant Extracts; Plants, Medicinal | 2020 |
2 other study(ies) available for eupatorin and genkwanin
Article | Year |
---|---|
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Topics: Aryl Hydrocarbon Hydroxylases; Binding Sites; Cell Line; Computer Simulation; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Enzyme Inhibitors; Flavones; Flavonoids; Humans; Recombinant Proteins; Substrate Specificity | 2011 |
Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia.
Topics: Antineoplastic Agents; Apoptosis; Flavonoids; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays | 2021 |